Stephen I. Deutsch

569 total citations
17 papers, 482 citations indexed

About

Stephen I. Deutsch is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Stephen I. Deutsch has authored 17 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 8 papers in Psychiatry and Mental health and 6 papers in Molecular Biology. Recurrent topics in Stephen I. Deutsch's work include Neuroscience and Neuropharmacology Research (8 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Schizophrenia research and treatment (5 papers). Stephen I. Deutsch is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Schizophrenia research and treatment (5 papers). Stephen I. Deutsch collaborates with scholars based in United States and Australia. Stephen I. Deutsch's co-authors include Richard B. Rosse, John Mastropaolo, Steven M. Paul, Maureen Fay-McCarthy, Ronit Weizman, A. Leslie Morrow, Jacqueline N. Crawley, Abraham Weizman, Barbara L. Schwartz and Robert C. Drugan and has published in prestigious journals such as Biological Psychiatry, Brain Research and Psychopharmacology.

In The Last Decade

Stephen I. Deutsch

17 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen I. Deutsch United States 12 256 180 89 85 76 17 482
Jantiena B. Sebens Netherlands 15 381 1.5× 216 1.2× 83 0.9× 52 0.6× 63 0.8× 24 540
K. Jhamandas Canada 11 346 1.4× 196 1.1× 71 0.8× 89 1.0× 74 1.0× 12 564
Annamarie J. Pond United States 9 322 1.3× 216 1.2× 28 0.3× 111 1.3× 72 0.9× 9 563
J.H. Connick United Kingdom 13 444 1.7× 289 1.6× 104 1.2× 134 1.6× 73 1.0× 27 764
Saurav Shrestha United States 13 248 1.0× 156 0.9× 80 0.9× 64 0.8× 117 1.5× 20 627
G. Sacchetti Italy 14 437 1.7× 245 1.4× 99 1.1× 107 1.3× 115 1.5× 32 714
Tonino Cuccheddu Italy 10 290 1.1× 121 0.7× 20 0.2× 97 1.1× 83 1.1× 11 435
Marcia J. Ramaker United States 12 226 0.9× 123 0.7× 31 0.3× 109 1.3× 95 1.3× 13 466
Virginia Lehmann-Masten United States 9 376 1.5× 213 1.2× 63 0.7× 67 0.8× 77 1.0× 9 497
Aurélie A. Boucher Australia 10 231 0.9× 119 0.7× 54 0.6× 78 0.9× 38 0.5× 12 601

Countries citing papers authored by Stephen I. Deutsch

Since Specialization
Citations

This map shows the geographic impact of Stephen I. Deutsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen I. Deutsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen I. Deutsch more than expected).

Fields of papers citing papers by Stephen I. Deutsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen I. Deutsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen I. Deutsch. The network helps show where Stephen I. Deutsch may publish in the future.

Co-authorship network of co-authors of Stephen I. Deutsch

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen I. Deutsch. A scholar is included among the top collaborators of Stephen I. Deutsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen I. Deutsch. Stephen I. Deutsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Drapalski, Amy L., et al.. (2001). Topiramate Improves Deficit Symptoms in a Patient with Schizophrenia when Added to a Stable Regimen of Antipsychotic Medication. Clinical Neuropharmacology. 24(5). 290–294. 33 indexed citations
2.
Tizabi, Yousef, John Mastropaolo, CHAN H. PARK, et al.. (1998). Both nicotine and mecamylamine block dizocilpine-induced explosive jumping behavior in mice: psychiatric implications. Psychopharmacology. 140(2). 202–205. 22 indexed citations
3.
Deutsch, Stephen I., et al.. (1997). Methylene Blue Adjuvant Therapy of Schizophrenia. Clinical Neuropharmacology. 20(4). 357–363. 50 indexed citations
4.
Rosse, Richard B., et al.. (1997). Pupillary Changes Associated With the Development of Stimulant-Induced Mania. Clinical Neuropharmacology. 20(3). 270–275. 8 indexed citations
5.
Schwartz, Barbara L., et al.. (1997). Effects of Nifedipine, a Calcium Channel Antagonist, on Cognitive Function in Schizophrenic Patients with Tardive Dyskinesia. Clinical Neuropharmacology. 20(4). 364–370. 24 indexed citations
6.
7.
Rosenberg, Paul B., Richard B. Rosse, Maureen Fay-McCarthy, et al.. (1996). Smooth Pursuit Eye Movements in the Evaluation of Famotidine Adjunctive Therapy of Schizophrenia: A Preliminary Report. Clinical Neuropharmacology. 19(3). 276–281. 1 indexed citations
8.
Lubitz, Dag K.J.E. Von, et al.. (1995). The effects of adenosine A3 receptor stimulation on seizures in mice. European Journal of Pharmacology. 275(1). 23–29. 68 indexed citations
9.
Rosse, Richard B., Maureen Fay-McCarthy, Joseph Collins, et al.. (1995). Famotidine Adjunctive Pharmacotherapy of Schizophrenia. Clinical Neuropharmacology. 18(4). 369–374. 13 indexed citations
10.
Koetzner, Lee, John Mastropaolo, & Stephen I. Deutsch. (1995). Facilitating role of m-chlorophenylbiguanide in a cocaine discrimination. Pharmacology Biochemistry and Behavior. 52(4). 815–818. 10 indexed citations
11.
Deutsch, Stephen I., Richard B. Rosse, & John Mastropaolo. (1994). Environmental Stress-Induced Functional Modification of the Central Benzodiazepine Binding Site. Clinical Neuropharmacology. 17(3). 205–228. 23 indexed citations
12.
PARK, CHAN H., et al.. (1993). Swim stress selectively alters the specific binding of a benzodiazepine antagonist in mice. Pharmacology Biochemistry and Behavior. 45(2). 299–304. 15 indexed citations
13.
Rosse, Richard B., Anil K. Malhotra, Sun Young Kim, & Stephen I. Deutsch. (1992). Visual fixation deficits and evidence of cognitive impairment in schizophrenia. Biological Psychiatry. 31(4). 412–414. 14 indexed citations
14.
Deutsch, Stephen I., et al.. (1992). Thalamic Pain Syndrome Complicating the Evaluation of a Patient With Poststroke Depression. Psychosomatics. 33(3). 335–337. 1 indexed citations
15.
Mastropaolo, John, et al.. (1992). Reduction of flurazepam's antiseizure efficacy persists after stress. Pharmacology Biochemistry and Behavior. 42(4). 681–684. 5 indexed citations
16.
Drugan, Robert C., A. Leslie Morrow, Ronit Weizman, et al.. (1989). Stress-induced behavioral depression in the rat is associated with a decrease in GABA receptor-mediated chloride ion flux and brain benzodiazepine receptor occupancy. Brain Research. 487(1). 45–51. 133 indexed citations
17.
Deutsch, Stephen I. & John M. Morihisa. (1988). Glutamatergic Abnormalities in Alzheimerʼs Disease and a Rationale for Clinical Trials with L-Glutamate. Clinical Neuropharmacology. 11(1). 18–35. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026